These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11803128)

  • 1. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
    Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
    Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC.
    Bettinetti GP; Sorrenti M; Rossi S; Ferrari F; Mura P; Faucci MT
    J Pharm Biomed Anal; 2002 Nov; 30(4):1173-9. PubMed ID: 12408907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose.
    Bettinetti G; Sorrenti M; Negri A; Setti M; Mura P; Melani F
    Pharm Res; 1999 May; 16(5):689-94. PubMed ID: 10350012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
    Mura P; Faucci MT; Maestrelli F; Furlanetto S; Pinzauti S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1015-24. PubMed ID: 12110386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
    Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
    Chowdary KP; Nalluri BN
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution.
    Bettinetti G; Melani F; Mura P; Monnanni R; Giordano F
    J Pharm Sci; 1991 Dec; 80(12):1162-70. PubMed ID: 1815076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
    Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
    J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties.
    Mura P; Zerrouk N; Mennini N; Maestrelli F; Chemtob C
    Eur J Pharm Sci; 2003 May; 19(1):67-75. PubMed ID: 12729863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
    Dahiya S; Pathak K
    Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
    Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
    AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties.
    Mura P; Faucci MT; Parrini PL
    Drug Dev Ind Pharm; 2001 Feb; 27(2):119-28. PubMed ID: 11266223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.